Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial

NCT07336992 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT07336992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07336992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lead sponsor
Hospices Civils de Lyon
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 2, 2026
Completion date
October 2, 2030
Enrollment
580 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spontaneous intracerebral hemorrhage